Graham Capital Management L.P. purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 3,760 shares of the insurance provider's stock, valued at approximately $995,000.
Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Humana by 8.9% during the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after purchasing an additional 1,143,662 shares during the last quarter. Dodge & Cox boosted its stake in Humana by 5.5% during the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock valued at $2,845,830,000 after purchasing an additional 557,175 shares during the period. Pzena Investment Management LLC boosted its stake in Humana by 6.1% during the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock valued at $1,013,133,000 after purchasing an additional 219,541 shares during the period. Davis Selected Advisers raised its position in shares of Humana by 3.3% during the 1st quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock worth $616,873,000 after buying an additional 74,434 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC raised its position in shares of Humana by 1.6% during the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider's stock worth $327,293,000 after buying an additional 19,613 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.
Analyst Ratings Changes
HUM has been the subject of a number of research reports. Sanford C. Bernstein increased their price target on Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a research note on Friday. Wall Street Zen lowered Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Morgan Stanley reduced their price target on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Royal Bank Of Canada increased their price target on shares of Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a research report on Thursday, August 21st. Finally, Barclays increased their price target on shares of Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research report on Friday. Seven equities research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $289.24.
Get Our Latest Research Report on Humana
Humana Stock Performance
NYSE:HUM traded down $4.07 during midday trading on Friday, reaching $307.94. The stock had a trading volume of 1,504,536 shares, compared to its average volume of 1,364,503. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $369.17. The firm's fifty day simple moving average is $261.46 and its 200-day simple moving average is $256.47. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The stock has a market capitalization of $37.04 billion, a P/E ratio of 23.63, a PEG ratio of 1.81 and a beta of 0.44.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the prior year, the company posted $6.96 earnings per share. The firm's revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.1%. Humana's dividend payout ratio (DPR) is currently 27.17%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.